Clindamycin palmitate HCl for oral solution 75mg/5ml

approved by DCGI as a new molecule on 14-12-2010 indicated for prophylaxis against alphahemolytic(viridans group) sreptococci before dental, oral and upper respiratory tract surgery. Clindamycin, an antimicrobial agent that has been in use worldwide for more than 3 decades, has been consistently effective in the treatment of infections involving a wide spectrum of facultative and strictly anaerobic bacteria. For the details on the same, kindly mail to meditextchd@gmail.com.